RESEARCH USE ONLY | Free Shipping Over £140

High Purity

Laboratory Tested

Secure Payments

Bank Transfer & More

Delivery

UK & Europe Wide

Tesamorelin 2mg

Tesamorelin 2mg

£28.00

Tesamorelin is a GHRH analogue extensively studied for its effects on visceral fat reduction, particularly in HIV-associated lipodystrophy. Research indicates benefits in improving body composition and metabolic parameters, with ongoing investigations exploring its applications in aging and cognitive function.

Category

Secure Payment

High Purity

Fast Delivery

  • Description
  • Additional Information
Tesamorelin is a growth hormone-releasing hormone (GHRH) analogue that has been the subject of extensive clinical research, particularly in the field of HIV-associated lipodystrophy. Scientific studies have demonstrated its ability to stimulate growth hormone production and reduce visceral adipose tissue. Clinical trials have shown Tesamorelin's efficacy in reducing abdominal fat in HIV-infected patients with lipodystrophy, leading to its FDA approval for this indication. Researchers have examined its effects on various metabolic parameters, with data suggesting improvements in lipid profiles and insulin sensitivity. Investigations have also explored its potential applications in other conditions characterized by excess visceral adiposity, such as aging-related abdominal fat accumulation. Preclinical studies have investigated Tesamorelin's potential neuroprotective properties, with some evidence indicating possible benefits in cognitive function and neuroplasticity. Additionally, research has explored its possible role in improving exercise capacity and muscle strength in older adults. The peptide's ability to selectively reduce visceral fat while potentially offering other metabolic and cognitive benefits has made it a subject of ongoing research in fields such as endocrinology, geriatrics, and HIV medicine.